Mechanical ventilation

Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE

Retrieved on: 
Friday, March 15, 2024
Hypercapnia, Respironics, VAPO, Business, Patient, Mechanical ventilation, Spirometry, Business development, Quality of life, Respiratory disease, OTCQX, NIV, COPD, FDA, HME, Hospital

EXETER, N.H., March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.

Key Points: 
  • EXETER, N.H., March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.
  • Dr. Jessica Whittle, Chief Medical Officer of Vapotherm, emphasized the company's commitment to improving the lives of hypercapnic patients in the home.
  • "(1)
    The highly anticipated Access365 home ventilator will be unveiled at MEDTRADE Dallas on March 27th.
  • Joe Army, President and CEO of Vapotherm, underscored the significance of the solution, stating, "Vapotherm is committed to supporting patients both in and out of the hospital.

Sands Point Center for Health & Rehabilitation obtains Enhanced Respiratory Care Standards of Care accreditation

Retrieved on: 
Tuesday, January 23, 2024
ACCS, Master of Education, Patient, Health, Consultant, MSHA, Friends, Mechanical ventilation, Society, Weaning, Accreditation, Rehabilitation, MBA, Doctor of Education, AARC, American College, RRT, Executive director, Marketing, Patient safety, MPH, Enhanced, Nursing

PORT WASHINGTON, N.Y., Jan. 23, 2024 /PRNewswire-PRWeb/ -- The Physician-Patient Alliance for Health & Safety (PPAHS) is pleased to announce that Sands Point Center for Health & Rehabilitation in Port Washington, NY has achieved or surpassed the Enhanced Respiratory Care Standards of Care. Sands Point is one of the first facilities to be awarded Enhanced Respiratory Care Accreditation in Long Island.

Key Points: 
  • PORT WASHINGTON, N.Y., Jan. 23, 2024 /PRNewswire-PRWeb/ -- The Physician-Patient Alliance for Health & Safety (PPAHS) is pleased to announce that Sands Point Center for Health & Rehabilitation in Port Washington, NY has achieved or surpassed the Enhanced Respiratory Care Standards of Care.
  • Dr. Jerry Gentile, EdD, MEd, MSHA, MPH, MBA, BSRT, BSHA, RRT (Consulting Director of Respiratory Care Services and Managing Partner, Respiratory Care Group, LLC) commented on the significance and importance of receiving accreditation, "I am pleased that our respiratory care unit at Sands Point Center has met the rigorous requirements of the Enhanced Respiratory Care Program.
  • The Enhanced Respiratory Care Standards of Care are supported and endorsed by the American Association for Respiratory Care .
  • Gene Gantt RRT, FAARC, whose team has developed and managed the Enhanced Respiratory Care program in Tennessee since 2013, said, "The Enhanced Respiratory Care Program is based on standards published by the American Association for Respiratory Care.

Portable/Transportable Ventilators Segment Set for Strong Growth with a CAGR of 6.7%, While Intensive Care Segment Records 4.9% CAGR - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 18, 2023
Biotechnology, General Health, Medical Devices, Hospitals, Health, Growth, Key finding attacks, Mechanical ventilation, Developed country, Getinge Group, GE, AI, Pet industry, Pharmaceutical industry

This growth is attributed to the rising demand for intensive care and portable/transportable ventilators.

Key Points: 
  • This growth is attributed to the rising demand for intensive care and portable/transportable ventilators.
  • Key Findings from the Report:
    Intensive Care Segment to Grow at 4.9% CAGR: The intensive care segment is expected to record a 4.9% CAGR, reaching US$15.9 billion by the end of the analysis period.
  • Strong Growth in the Portable/Transportable Segment: The portable/transportable segment is estimated to grow at a robust CAGR of 6.7% over the next eight years.
  • This growth is driven by the demand for ventilators that provide mobility and flexibility for patient care.

Disability Organizations and Individuals Partner to Fight the Deadly and Discriminatory Public Policy of Physician-Assisted Suicide

Retrieved on: 
Wednesday, April 26, 2023
United States Navy, Pressure, United Spinal Association, California End of Life Option Act, Depression, Life, Suicide, Central District, Disability, Fourteenth Amendment, Death, Quality of life, NDY, Mechanical ventilation, Rehabilitation Act of 1973, Paralysis, Americans with Disabilities Act of 1990, JAMA Internal Medicine, Rehabilitation, Community Activities Restrictions Enforcement, District court, Patient, Risk, Tetraplegia, Palliative care, Court, Racism, Defendant, Research, Mental health, Douglas v. U.S. District Court ex rel Talk America, Muscular dystrophy, Constitution, Pneumonia, Caregiver, Suicide in India, Nursing, Life insurance

LOS ANGELES, April 26, 2023 /PRNewswire/ -- Today, the United Spinal Association ("United Spinal"), Not Dead Yet ("NDY"), Institute for Patients' Rights ("IPR"), Communities Actively Living Independent & Free ("CALIF"), and individual plaintiffs, Lonnie VanHook and Ingrid Tischer, filed a lawsuit in the U.S. District Court for the Central District of California, asking that California's End of Life Option Act (EOLOA) be declared unlawful and unconstitutional. The current state law, passed in 2021, permits a physician to prescribe lethal drugs to suicidal patients and removed or weakened many of the supposed "safeguards" in the original law. Death by suicide can now be fast-tracked in 48 hours and doctors who have professional, moral, or ethical objections to writing a lethal prescription for a patient now must participate in the EOLOA process. EOLOA, by design, is unregulated by any California public entity, leaving patients and their loved ones at grave risk of harm and without recourse.

Key Points: 
  • EOLOA, by design, is unregulated by any California public entity, leaving patients and their loved ones at grave risk of harm and without recourse.
  • Van Swearingen, Kara Janssen, and Michael Nuñez from the firm join Mr. Bien in representing the plaintiffs as well as co-counsel Haben Girma.
  • Stopping California's assisted suicide law is both a disability rights and health equity issue.
  • Assisted suicide laws make it far too easy for a system stacked against us to provide a cheap, easy way out."

World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.

Retrieved on: 
Thursday, November 24, 2022
Health, Infectious Diseases, COVID-19, Clinical Trials, Research, Science, Pharmaceutical, Safety, Public health, Convidecia, VLP, Pain, International Society, CanSino Biologics, National Medical Products Administration, Research, Ageing, Tidal volume, Multimedia, Noble gas, Atmosphere of Earth, Chronic obstructive pulmonary disease, COVID-19, Partnership, Severe acute respiratory syndrome coronavirus 2, McGrath, Adenoviridae, Vaccine, Nassar Ikram, WHO, News, Enterprise Ireland, Mechanical, Mechanical ventilation, Vaccination, Use, Effect, Growth, DOI, Diagnosis, Inhalation, COPD, Medtech, Ventilation, Patient, Global Initiative, HKEX, McLoughlin, SSE, COVID19, Pharmaceutical industry, Medical device, Lancet, Medicine

This route mimics the natural infection pathway of the respiratory virus COVID-19 and may create additional benefits through generating mucosal immunity.

Key Points: 
  • This route mimics the natural infection pathway of the respiratory virus COVID-19 and may create additional benefits through generating mucosal immunity.
  • 2,3
    Further clinical trials of the inhaled vaccine are progressing in Asia and Latin America to support other country approvals for this innovative technology.
  • John Power, Aerogen CEO & Founder said The world has an urgent need for an effective, low-cost, globally scalable, and globally accessible solution to mass vaccination.
  • We are delighted with the news of approval and public rollout in China and look forward to further approval of inhaled vaccines around the world.

JobsFirstNYC Partners with Workforce AI Leader, SkyHive, to Revolutionize Skills-Based Employment in New York City

Retrieved on: 
Wednesday, October 5, 2022
Green economy, Time, Health care, SkyHive, Growth, Mechanical ventilation, Employment, Forbes, Education, COVID, Organization, World Economic Forum, Intelligence, East Side House Settlement, Partnership, Technology, Student, Software, CEO, COVID-19, Solution, Creative industries, Management, Tech

NEW YORK, Oct. 5, 2022 /PRNewswire/ -- The future of work is skills-based, not degree-based. Imagine being able to build reskilling and upskilling plans for an entire neighborhood, one that showcases the skills currency of that community to its residents – and builds upon their unique strengths and abilities – creating direct pathways to higher-wage jobs laying a foundation for long-term economic mobility.

Key Points: 
  • For young people to take advantage of these opportunities, we must have an intelligent workforce system that can predict these shifts.
  • "We applaud JobsFirstNYC for breaking down barriers so young adults in New York City and surrounding communities can achieve financial security and self-sufficiency in today's labor market.
  • The partnerships have reconnected 10,200+ young adults to education and employment and raised and leveraged $30M of public and private investment.
  • Since 2006, JobsFirstNYC has worked with organizations and institutions across New York and developed models that have been replicated and integrated across the workforce system.

Leviton Introduces New Decora® Humidity Sensor and Fan Controls

Retrieved on: 
Wednesday, September 28, 2022
Humidity, Switch, Leviton, Indoor air quality, FUTURE, Part, Environment, Computer, Automation, Lighting, LED, Mechanical ventilation, Solution, Water, Multimedia, View, Heating, ventilation, and air conditioning

MELVILLE, N.Y., Sept. 28, 2022 /PRNewswire/ -- Leviton today announced the introduction of its new Decora Humidity Sensor and Fan Control devices, designed to work with ventilation fans to create a more comfortable environment in areas of the home prone to dampness and humidity.

Key Points: 
  • MELVILLE, N.Y., Sept. 28, 2022 /PRNewswire/ -- Leviton today announced the introduction of its new Decora Humidity Sensor and Fan Control devices, designed to work with ventilation fans to create a more comfortable environment in areas of the home prone to dampness and humidity.
  • Leviton Decora Humidity Sensor and Fan Controls are available in two models - a Single Pole Humidity Sensor and Fan Control, and a Combination Humidity Sensor and Fan Control with Light Switch.
  • Leviton Decora Humidity Sensor and Fan Controls comply with the requirements of 2019 and 2022 California Title 22, Part 6, Indoor Air Quality and Mechanical Ventilation as well as CALGREEN, Part II, Indoor Air Quality and Exhaust.
  • To learn more about the Leviton Decora Humidity Sensor and Fan Controls, visit www.leviton.com/humiditysensor .

Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery

Retrieved on: 
Thursday, December 9, 2021
Technology, Mobile, Wireless, Medical Devices, Infectious Diseases, Clinical Trials, Biotechnology, Other Health, Health, Data Management, CanSino Biologics, ISO 10993, Risk, Research, COPD, NMPA, COVID19, Tidal volume, Adenoviridae, SSE, International Society, McLoughlin, Vaccine, Patient, Mechanical ventilation, Partnership, Atmosphere of Earth, Conditional, McGrath, CRM197, Mechanical, Use, Global Initiative, Ventilation, Multimedia, Effect, COVID-19, Public health, HKEX, Diagnosis, Chronic obstructive pulmonary disease, Noble gas, Pharmaceutical industry, Medical device

Following months of collaborative development work, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIOs Recombinant Novel Coronavirus Vaccine Convidecia utilizing Aerogens proprietary vibrating mesh aerosol drug delivery technology.

Key Points: 
  • Following months of collaborative development work, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIOs Recombinant Novel Coronavirus Vaccine Convidecia utilizing Aerogens proprietary vibrating mesh aerosol drug delivery technology.
  • Dr. Xuefeng YU, Chairman and Chief Executive Officer of CanSinoBIO commented; Our partnership with Aerogen started in 2013 and for almost a decade, weve been advancing the possibility of aerosol drug delivery.
  • The innovative development on the inhaled delivery of COVID-19 vaccine is the testimony of our collaborative efforts.
  • The Aerogen Solo is a closed-system, single-patient-use aerosol drug delivery technology3 that mitigates the transmission of patient-generated infectious aerosol during ventilation4-9.

QSC Introduces New Q-SYS Video & Control Products

Retrieved on: 
Wednesday, November 10, 2021
University, Data Management, Education, Technology, Other Technology, Telecommunications, Software, Networks, Audio, Video, Internet, VoIP, USB, Primetime Emmy Award for Outstanding Technical Direction, Camerawork, Video Control for a Series, QSC, Engineering, CSS, Mark (given name), Google Meet, 2018 UCI Track Cycling World Championships – Men's keirin, RGB, Mechanical ventilation, Solution, PTZ, DSP, Microsoft, Video game console, Typesetting

Native to the Q-SYS OS, these scalable products seamlessly integrate with any Q-SYS system to meet the unique needs of any modern, high-value collaboration space.

Key Points: 
  • Native to the Q-SYS OS, these scalable products seamlessly integrate with any Q-SYS system to meet the unique needs of any modern, high-value collaboration space.
  • With these new conference cameras, QSC is demonstrating its commitment to providing scalable video conferencing solutions for collaboration spaces in an effort to create experience equity for both remote and in-room participants, says Mike Brandes, Product Manager, Q-SYS Video Solutions, QSC.
  • Furthermore, users can combine these new products with smaller channel count processing options found in the Q-SYS Core Nano or Q-SYS Core 8 Flex to expand software-based audio, video & control into smaller collaboration spaces.
  • These next-generation Q-SYS touch screens give a more modern aesthetic and high performance required for todays hybrid high-value spaces, says Greg Mattson, Product Manager, Q-SYS Control, QSC.

New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients

Retrieved on: 
Monday, September 6, 2021
Science, Health, Research, Medical Devices, Medicine, Clinical medicine, Medical specialties, Oxygen, Intensive care medicine, Respiratory therapy, Anesthesia, Masimo, Medical monitoring, Pulse oximetry, Monitoring, Mechanical ventilation

Noting the importance of optimizing preoxygenation in patients needing ETI, the researchers sought to evaluate whether ORi could provide early warning of impending hypoxemia during the procedure, because ORi supplies information beyond the range explored by SpO2.

Key Points: 
  • Noting the importance of optimizing preoxygenation in patients needing ETI, the researchers sought to evaluate whether ORi could provide early warning of impending hypoxemia during the procedure, because ORi supplies information beyond the range explored by SpO2.
  • Secondarily, the investigators evaluated whether a decline in ORi during preoxygenation predicted the occurrence of mild hypoxemia during ETI.
  • The inclusion criteria for this study were ICU admission with a need for ETI and an SpO2/FiO2 ratio above 214.
  • Oxygen reserve index for noninvasive early hypoxemia detection during endotracheal intubation in intensive care: the prospective observational NESOI study.